Modifiedsierra health and lifePolicy 2026T0400Z

Virtual Upper Gastrointestinal Endoscopy (CT/MR virtual endoscopy)

This policy governs the use and medical necessity determination of virtual upper GI endoscopy (3-D CT or 3-D MRI virtual gastroscopy/esophagography) for members covered under the payer's commercial and individual exchange benefit plans.

Policy Summary

Payersierra health and life

PolicyVirtual Upper Gastrointestinal Endoscopy (CT/MR virtual endoscopy)

Policy CodePolicy 2026T0400Z

Change TypeTemplate update and consolidation

Effective DateJan 1, 2026

Next Review Date

Key ActionVerify member benefit and obtain prior authorization when required per the member's benefit plan.

SourceLink

POLICY UPDATE CHANGES

Created shared policy version to support application to Oxford plan membership and archived previous policy version 2025T0400Y and DIAGNOSTIC 045.18.

no RCTsrandomized controlled trials available

observationalsupporting evidence types

98%detection rate (primary tumor)

89%T staging accuracy

78%

Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.

2026T0400Zinternal id

Coverage Criteria for Virtual Upper GI Endoscopy

Not medically necessary

Coverage stance

Primary coverage determination: Virtual upper GI endoscopy using 3-D CT or 3-D MRI is unproven and not medically necessary for detecting and evaluating upper GI lesions due to insufficient evidence of efficacy.

Based on available observational studies and lack of randomized controlled trials demonstrating clinical utility.

Coverage considerations

Guiding clinical stance based on referenced evidence and guideline statements

Imaging for superficial GI lesions: ESGE recommends evaluation by an experienced endoscopist using high-definition white-light endoscopy and chromoendoscopy with validated classifications; routine EUS, CT, MRI, or PET-CT before endoscopic resection is not recommended.

Providers should prioritize endoscopic assessment over routine cross-sectional imaging for superficial lesions unless specific clinical indications exist.

When MDCT with virtual gastroscopy may be useful: MDCT with combined water and air distention plus MPR and virtual gastroscopy can improve preoperative local staging accuracy (especially T staging) and detection of primary gastric tumors in smaller prospective studies; consider when endoscopic assessment is insufficient or when staging for surgical planning is required.

Evidence includes Chen et al. reporting improved detection rates and superior T-staging accuracy with MPR and virtual gastroscopy (detection up to 98% and T staging accuracy 89% for MPR).

Routine use of cross-sectional imaging (CT, MRI, PET-CT) or endoscopic ultrasound (EUS) solely as a pre‑procedure step before endoscopic resection of superficial gastrointestinal lesions is not supported. The European Society of Gastrointestinal Endoscopy (ESGE) does not recommend routine performance of EUS, CT, MRI, or PET‑CT before endoscopic resection (strong recommendation), and advises evaluation by an experienced endoscopist using high‑definition white‑light endoscopy and chromoendoscopy with validated classifications as the standard pre‑resection assessment. This policy therefore does not support routine cross‑sectional imaging or EUS in place of high‑quality endoscopic assessment.

The 2022 ESGE guideline for superficial GI lesions explicitly states that evaluation should be performed by an experienced endoscopist using high‑definition white‑light endoscopy and chromoendoscopy with validated classifications and makes a strong recommendation against routine performance of EUS, CT, MRI, or PET‑CT prior to endoscopic resection. Providers should prioritize endoscopic assessment over routine cross‑sectional imaging when planning endoscopic resection of superficial lesions unless there are clear, case‑specific indications for additional imaging.

Virtual upper gastrointestinal endoscopy using 3‑D CT or 3‑D MRI (also termed virtual gastroscopy or virtual esophagography) is considered unproven and not medically necessary for detecting and evaluating upper GI lesions due to insufficient evidence of efficacy. Use of this technique for routine diagnostic evaluation is therefore not supported by this policy.

When high‑quality endoscopic evaluation (experienced endoscopist, high‑definition white‑light endoscopy and chromoendoscopy with validated classifications) is available, routine cross‑sectional imaging (CT, MRI, PET‑CT) or EUS solely for pre‑endoscopic resection staging of superficial lesions is not recommended. ESGE guidance frames endoscopic assessment as the preferred pathway and indicates that routine imaging prior to endoscopic resection would be unnecessary in the absence of specific clinical indications.

Coding and Identifiers

Applicable procedure codes (listed for reference)CPT

76497	Unlisted computed tomography procedure (e.g., diagnostic, interventional)
76498	Unlisted magnetic resonance procedure (e.g., diagnostic, interventional)

FDA device product codesmixed

JAK	FDA product code classification for some imaging devices used to create virtual endoscopy images
LLZ	FDA product code classification for some imaging devices used to create virtual endoscopy images
LNH	FDA product code classification for some imaging devices used to create virtual endoscopy images

inv-09: study sample size

StudyChen et al. (2007) prospective MDCT preoperative staging study

Sample size55 consecutive individuals with gastric cancer

Population detailsParticipants had endoscopic biopsy confirmation and underwent partial or complete gastrectomy

Imaging protocolMDCT with air distention (virtual gastroscopy), water distention, contrast-enhanced transverse imaging, and multiplanar reconstructions (MPR)

Provider Actions and Billing Guidance

Note

Procedure codes listed — coverage not implied

Listing of procedure or diagnosis codes in this policy is for reference only and does not imply coverage. Verify member-specific benefits and plan documents to determine coverage and reimbursement. Inclusion of a code does not guarantee payment.

Procedure codes listed — coverage not implied: 76497 (Unlisted CT procedure), 76498 (Unlisted MR procedure)
Check member specific benefit plan document and applicable federal/state mandates before billing
If Medicare Advantage, verify applicable NCDs/LCDs or MAO determinations

Prior Authorization

Verify prior authorization

Prior authorization may be required by the member's plan. Confirm and obtain any required prior authorization before scheduling virtual upper GI endoscopy procedures to avoid claim denials.

Verify prior authorization requirements with the payer for imaging-based procedures used to evaluate upper GI lesions

Background

Virtual upper GI endoscopy (also described as virtual gastroscopy or virtual esophagography) employs three‑dimensional reconstructions from CT or MRI datasets to generate endoscopy‑like views of the esophagus, stomach, and proximal small bowel without inserting an endoscope. It is proposed as a noninvasive alternative to conventional endoscopy for visualization of mucosal surfaces and for some preoperative staging tasks, with potential advantages including avoidance of sedation and a lower immediate procedural risk profile; however, it cannot obtain tissue biopsies and, for CT based techniques, involves ionizing radiation. Evidence remains insufficient to establish clinical utility compared with conventional endoscopy.

Definitions

inv-19: Virtual upper GI endoscopy definition

DefinitionA noninvasive imaging procedure using 3-D CT or 3-D MRI reconstruction (virtual gastroscopy/esophagography) to generate endoscopy-like views of the upper gastrointestinal tract without insertion of an endoscope.

Typical indicationsProposed to evaluate symptoms such as nausea, reflux, abdominal pain, unexplained weight loss; identification of varices, ulcers, inflammation, precancerous conditions, and hernias; and preoperative gastric cancer staging.

Key advantagesUsually does not require anesthesia or sedation; allows post-acquisition image manipulation (magnification, angle adjustment)

LimitationsLess fine-detail resolution than conventional endoscopy; cannot obtain biopsies during the exam; CT incurs radiation exposure when used.

inv-20: MDCT with MPR and virtual gastroscopy definition

Policy Summary

Payersierra health and life

PolicyVirtual Upper Gastrointestinal Endoscopy (CT/MR virtual endoscopy)

Policy CodePolicy 2026T0400Z

Change TypeTemplate update and consolidation

Effective DateJan 1, 2026

Next Review Date

Key ActionVerify member benefit and obtain prior authorization when required per the member's benefit plan.

SourceLink

On This Page

If required, include clinical rationale and relevant prior tests when requesting authorization

Documentation Required

Preferred diagnostic pathway

Preferred diagnostic pathway: conventional endoscopy (esophagogastroduodenoscopy) with biopsy remains the standard for diagnosis and tissue sampling. Virtual upper GI endoscopy is considered investigational/unproven for detection and evaluation of upper GI lesions and should not replace standard endoscopy when biopsy or therapeutic intervention may be required.

Do not substitute virtual endoscopy in place of conventional endoscopy when biopsy or direct visualization with therapeutic capability is indicated
If lesion identified on imaging, perform conventional endoscopy for biopsy and management

Documentation Required

Documentation and plan verification

Providers must ensure required documentation is present and accurate when submitting claims: include clinical indication, prior diagnostic studies, reason virtual technique is being used (if applicable), and documentation of discussion regarding limitations (no biopsy capability, potential radiation exposure for CT-based techniques).

Document clinical indication (e.g., unexplained weight loss, suspected lesion) and rationale for imaging study
Include reports of any prior endoscopic evaluations and findings
If CT-based virtual endoscopy used, document radiation considerations discussed with patient

Billing Rule

Coding and documentation references

Coding and documentation must reference the unlisted procedure codes when no specific CPT exists. Use 76497 for unlisted CT procedures and 76498 for unlisted MR procedures and supply supporting operative/imaging reports and clinical rationale with claims.

Use CPT 76497 for unlisted computed tomography procedures when applicable
Use CPT 76498 for unlisted magnetic resonance procedures when applicable
Attach complete imaging reports and clinical justification when billing unlisted codes

Denial Risk

Not medically necessary designation

Not medically necessary designation: Virtual upper gastrointestinal endoscopy (3-D CT or 3-D MRI) is considered unproven and not medically necessary for detecting and evaluating upper GI lesions due to insufficient evidence of efficacy. Do not bill expecting routine coverage for these procedures without prior authorization and clear benefit plan language permitting coverage.

Expectation of denial if billed as a substitute for conventional endoscopy for diagnosis or biopsy
Provider should obtain prior authorization and supply strong clinical justification if seeking coverage

Prior Authorization

Member benefit verification required

Before performing or billing for virtual upper GI endoscopy, verify member benefits, prior authorization, and any plan-specific exclusions. The member specific benefit plan governs in case of conflict.

Member benefit verification required — confirm coverage, prior auth, and patient cost-sharing
When in doubt, contact the payer's provider services for plan-specific guidance

Multi-detector computed tomography (MDCT) protocol including water and/or air distention with contrast-enhanced transverse imaging, multiplanar reconstructions (MPR), and virtual endoscopic (virtual gastroscopy) views to evaluate gastric lesions and local staging.

Protocol elementsAir distention for virtual gastroscopy images; water distention for dynamic contrast-enhanced transverse and MPR images; combination improves tumor detection and T staging accuracy.

Reported performanceChen et al. reported detection rates: transverse 91%, MPR 96%, combined MPR+virtual gastroscopy 98%; T‑staging accuracy: MPR 89% vs transverse 73% (p<0.01)

inv-21: Endoscopic resection (ER) definition

DefinitionEndoscopic resection (ER) refers to endoscopic removal of superficial gastrointestinal lesions, with evaluation and management led by an experienced endoscopist using high-definition white-light endoscopy and chromoendoscopy and validated classifications.

Guideline stanceESGE (2022) recommends endoscopic evaluation by experienced endoscopist and does not recommend routine EUS, CT, MRI, or PET-CT before ER for superficial lesions.

ImplicationRoutine cross-sectional imaging solely for pre-ER staging is not recommended when high-quality endoscopic assessment is available.